A forum on clinical transformation and application of molecular probes was held during the 2021 National Conference on Molecular Imaging in Guangzhou, capital of Guangdong province, on Dec 28.

The forum highlighted molecular imaging’s role in solving practical clinical problems, including disease diagnosis, staging, in vivo molecular typing, efficacy monitoring, surgical navigation and accurate individualized treatment guidance.

It was presided over by Tian Jie, professor and vice-dean of the School of Medical Science and Engineering at Beihang University, and Hu Shuo, director of the PET Center of Xiangya Hospital at Central South University.

Gao Fabao, deputy director of the Clinical Imaging Center of the WCH at SCU, delivers a speech entitled Basic and Clinical Studies on Cardiovascular Magnetic Resonance Molecular Imaging. [Photo/BSC Molecular Imaging Academic Subgroup]

Gao Fabao, deputy director of the Clinical Imaging Center of the West China Hospital (WCH) at Sichuan University (SCU), delivered a speech entitled Basic and Clinical Studies on Cardiovascular Magnetic Resonance Molecular Imaging in which he explained his team’s research on the clinical and basic studies on myocardial tissue characterization by magnetic resonance imaging.

Zhu Xiaohua, director of the Department of Nuclear Medicine at Tongji Hospital of HUST, delivers a report entitled Immuno-PET Imaging and Its Clinical Application. [Photo/BSC Molecular Imaging Academic Subgroup]

Zhu Xiaohua, director of the Department of Nuclear Medicine at Tongji Hospital of Huazhong University of Science and Technology (HUST), gave a report entitled Immuno-PET Imaging and Its Clinical Application. Zhu talked about the integration of molecular imaging, diagnosis and treatment in nuclear medicine. 

Lan Xiaoli, director of the Department of Nuclear Medicine of the Union Hospital at Tongji Medical College of HUST, presents 18F-5-FPN at the forum. [Photo/BSC Molecular Imaging Academic Subgroup]

Lan Xiaoli, director of the Department of Nuclear Medicine and the Teaching and Research Office of the Union Hospital at Tongji Medical College of HUST, presented 18F-5-FPN, a new imaging agent targeting malignant melanoma, and showed its preliminary clinical transformation research results.

Lyu Su, deputy director of the Radiology Department at the WCH of SCU, reports on the immune mechanism of new imaging subtypes of schizophrenia. [Photo/BSC Molecular Imaging Academic Subgroup]

Lyu Su, deputy director of the Radiology Department at the WCH of SCU, reported on the immune mechanism of new imaging subtypes of schizophrenia, and displayed the academic achievements of his research team, including the intracephalic changes of high-risk groups for mental illness, the impact of drug treatment on brain structure and function, and image-based disease subtype analysis.

Tao Xiaofeng, director of the Radiology Department at Shanghai Ninth People’s Hospital affiliated to the School of Medicine at Shanghai Jiao Tong University, gives a lecture entitled Molecular-targeted Imaging of Head and Neck Squamous Cell Carcinoma and Its Application. [Photo/BSC Molecular Imaging Academic Subgroup]

Tao Xiaofeng, director of the Radiology Department at Shanghai Ninth People’s Hospital affiliated to the School of Medicine at Shanghai Jiao Tong University, gave a lecture entitled Molecular-targeted Imaging of Head and Neck Squamous Cell Carcinoma and Its Application, and demonstrated the c-Met molecular imaging probe’s effectiveness in inhibiting the growth and migration of tumor cells and accelerating the apoptosis of such cells.